Considerations for Using Clinical Practice Data to Study COVID-19 Vaccines in Patients With Cancer

Larry Han¹

Affiliations

Larry Han. JAMA Oncol. 2025.

. 2025 Sep 1;11(9):965-967.

doi: 10.1001/jamaoncol.2025.1937.

Larry Han¹

¹ Department of Public Health and Health Sciences, Northeastern University, Boston, Massachusetts.

No abstract available

Comment in

COVID-19 Vaccine Booster Uptake and Effectiveness Among US Adults With Cancer.
Skarbinski J, Elkin EP, Ziemba YC, Kazemian E, Wilson BM, Siddiqui H, Schleicher CB, Hsiao CA, Nugent JR, Reckamp KL, Merchant A, Crawford JM, Zidar DA, Kushi LH, Figueiredo JC. Skarbinski J, et al. JAMA Oncol. 2025 Sep 1;11(9):999-1010. doi: 10.1001/jamaoncol.2025.2020. JAMA Oncol. 2025. PMID: 40674059 Free PMC article.
Risk Factors for COVID-19-Related Hospitalization and Death in Patients With Cancer: The National Cancer Institute COVID-19 in Cancer Patients Study (NCCAPS).
Rini BI, Best AF, Bowman MD, Mishkin GE, Denicoff AM, Rubinstein LV, Harris L, Geiger AM, Mark NM, Pergam SA, Warner JL, Khorana AA, Gnjatic S, Yen TWF, Liles DK, Bestvina CM, Shah NJ, Norrell JT, Hershman DL, Holter-Chakrabarty JL, Poklepovic AS, Chanock SJ, Sankaran H, Korde LA. Rini BI, et al. JAMA Oncol. 2025 Sep 1;11(9):990-998. doi: 10.1001/jamaoncol.2025.2010. JAMA Oncol. 2025. PMID: 40674082 Free PMC article.